Sort
141,003 grants matching “cytokine”
Characterizing the viral and host effector mechanisms that govern HIV-1 rebound
$812,291Katharine June Bar · University Of Pennsylvania · R01 · FY2021 · AI
INITIATION/PERPETUATION OF ALLERGIC RESPONSES &ASTHMA
$812,223Beth Israel Deaconess Medical Center · U19 · FY2000 · AI
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation
$812,208Stuart C Sweet · Washington University · U01 · FY2009 · AI
Harnessing the CARD8 Inflammasome for HIV Reservoir Elimination
$812,142Liang Shan · Washington University · R01 · FY2023 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$812,000Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2024 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$811,997Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD
$811,977Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2024 · NS
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$811,957University Of Texas Sw Med Ctr/Dallas · R01 · FY2002 · DK
Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis
$811,768Pratik Pandharipande · Vanderbilt University · R01 · FY2012 · HL
Immuno-Genetic Epidemiology of Complex Malaria in India
$811,765Jane Carlton · New York University · U19 · FY2014 · AI
Epigenetic Therapy for Thoracic Malignancies
$811,718David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
COSTIMULATION AND CYTOKINES IN TOLERANCE
$811,704University Of Pennsylvania · P01 · FY2000 · AI
Establishment and Validation of a Novel Animal Model of Fibromyalgia
$811,652Jianren Mao · Massachusetts General Hospital · R33 · FY2025 · NS
REGULATION OF NF-KAPPA B
$811,614Inder Mohan Verma · Salk Institute For Biological Studies · R37 · FY2008 · AI
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II
$811,565Peter M. Pushko · Medigen, Inc. · R44 · FY2016 · AI
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$811,554Shabaana A. Khader · Washington University · R01 · FY2021 · AI
Pathogenesis of Burkholderia mallei and pseudomallei
$811,455Frank Gherardini · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
PROTECTIVE MECHANISMS WITH ATTENUATED LENTIVIRAL VACCINE
$811,239University Of California Davis · R01 · FY2000 · AI
M.D. Anderson Education Program in Cancer Prevention
$811,123Robert M. Chamberlain · University Of Tx Md Anderson Can Ctr · R25 · FY2008 · CA
T Cell Alternative p38 Activation Pathway
$811,121Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder
$810,889Elena Molokanova · Neurano Bioscience · R44 · FY2025 · DA
T-cell activation and exhaustion in the HIV-positive female genital tract
$810,839Raymond Scott McClelland · University Of Washington · R01 · FY2023 · HD
Improving Mitral Compensation in Ischemic Regurgitation
$810,817Robert A Levine · Massachusetts General Hospital · R01 · FY2013 · HL
Towards a Vaccine to Prevent Toxoplasmosis
$810,759Rima L McLeod · University Of Chicago · U01 · FY2012 · AI
Demystifying the antiviral activity of the IgG3+ antibody response
$810,753Galit Alter · Massachusetts General Hospital · R37 · FY2018 · AI